Prostate cancer Cancer Malignant neoplasm of prostate
Conditions
Interventions
Prospective randomised controlled trial comparing 1% and 2% lignocaine as a form of anaesthesia prior to prostate biopsy
Sponsors
Department of Health
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: CaP (prostate cancer) patients
Exclusion criteria
Exclusion criteria: Does not match inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference on visual analogue scale (VAS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed